彭澎;向阳;
PENG Peng;XIANG Yang;Department of Gynecological Oncology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College;

• 1:中国医学科学院北京协和医学院北京协和医院妇科肿瘤中心

摘要(Abstract)：

一直以来,国际妇产科联盟(International Federation of Gynecology and Obstetrics,FIGO)的宫颈癌分期都是临床分期。但随着诊断技术的发展、手术方式的进步以及对宫颈癌预后的了解加深,过去的FIGO分期已不能很好地推测宫颈癌预后及指导临床治疗选择。因此,FIGO在2009年宫颈癌分期的基础上,引入了近10年来宫颈癌诊治的新进展,形成了2018年宫颈癌分期。新的分期主要体现在肿瘤大小的分层更加细化,且纳入了淋巴结转移情况。本文对FIGO的2018年宫颈癌分期变化及其临床意义进行解读。
For years,the cervical cancer staging of the International Federation of Gynecology and Obstetrics( FIGO) are of clinical staging. However,with the development of diagnostic techniques,advances in surgical procedures,and a deeper understanding of the prognosis of cervical cancer,the old FIGO staging has not been able to well predict the prognosis of cervical cancer and to help the choice of treatment. Therefore,on the basis of the cervical cancer staging in 2009,FIGO introduced new progress in the diagnosis and treatment of cervical cancer in the past 10 years and formed the new staging of cervical cancer in 2018. The new staging system mainly reflects a more detailed stratification of the tumor size and the inclusion of lymph node metastasis.This article explains the changes in the cervical cancer staging of FIGO 2018 and its clinical significance.

关键词(KeyWords)： 国际妇产科联盟;宫颈癌;指南解读
International Federation of Gynecology and Obstetrics;cervical cancer;guideline interpretation

Abstract:

Keywords:

基金项目(Foundation): 中国医学科学院医学与健康科技创新工程(2017-I2M-1-002)

作者(Author): 彭澎;向阳;
PENG Peng;XIANG Yang;Department of Gynecological Oncology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College;

Email:

DOI:

参考文献(References)：

• [1] Pecorelli S. Revised FIGO staging for carcinoma of the vulva,cervix, and endometrium[J]. Int J Gynaecol Obstet,2009,105:103-104.
• [2] Bhatla N,Denny L. FIGO Cancer Report 2018[J]. Int J Gynaecol Obstet,2018,143:2-3.
• [3] Matsuo K,Machida H,Mandelbaum RS,et al. Trachelectomy for stage IB1 cervical cancer with tumor size> 2 cm:trends and characteristics in the United States[J]. J Gynecol Oncol,2018,29:e85.
• [4] Machida H,Mandelbaum RS,Mikami M,et al. Characteristics and outcomes of reproductive-aged women with earlystage cervical cancer:trachelectomy vs hysterectomy[J].Am J Obstet Gynecol,2018,219:461. e1-461. e18.
• [5] Li J,Wu X,Li X,et al. Abdominal radical trachelectomy:Is it safe for IB1 cervical cancer with tumors>/=2 cm?[J]. Gynecol Oncol,2013. 131:87-92.
• [6] Plante M. Evolution in fertility-preserving options for earlystage cervical cancer:radical trachelectomy,simple trachelectomy,neoadjuvant chemotherapy[J]. Int J Gynecol Cancer,2013,23:982-989.
• [7] Marchiole P,Benchaib M,Buenerd A,et al. Oncological safety of laparoscopic-assisted vaginal radical trachelectomy(LARVT or Dargent’ s operation):a comparative study with laparoscopic-assisted vaginal radical hysterectomy(LARVH)[J]. Gynecol Oncol,2007,106:132-141.
• [8] Creasman WT,Kohler MF. Is lymph vascular space involvement an independent prognostic factor in early cervical cancer?[J]. Gynecol Oncol,2004,92:525-529.
• [9] Selman TJ,Mann C,Zamora J,et al. Diagnostic accuracy of tests for lymph node status in primary cervical cancer:a systematic review and meta-analysis[J]. CMAJ,2008,178:855-862.
• [10] Singh N,Arif S. Histopathologic parameters of prognosis in cervical cancer—a review[J]. Int J Gynecol Cancer,2004,14:741-750.
• [11] Ramirez PT,Jhingran A,Macapinlac HA,et al. Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer:a prospective correlation of surgical findings with positron emission tomography/computed tomography findings[J]. Cancer,2011, 117:1928-1934.
• [12] Pol FJ,Zusterzeel PL,van Ham MA,et al. Satellite lymphovascular space invasion:An independent risk factor in early stage cervical cancer[J]. Gynecol Oncol, 2015,138:579-584.
• [13] Hutchcraft ML,Smith B,McLaughlin EM,et al. Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancer[J]. Gynecol Oncol,2019,153:255-258.
• [14] Sedlis A,Bundy BN,Rotman MZ,et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy:A Gynecologic Oncology Group Study[J]. Gynecol Oncol,1999, 73:177-183.
• [15] Matsuo K,Machida H,Mandelbaum RS,et al. Validation of the 2018 FIGO cervical cancer staging system[J]. Gynecol Oncol,2019,152:87-93.
• [16] Wright JD,Matsuo K,Huang Y,et al. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines[J]. Obstet Gynecol,2019,134:49-57.
• [17] Ayhan A,Aslan K,Oz M,et al. Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer[J]. Arch Gynecol Obstet,2019,300:675-682.